New York, NY, May 26, 2016 – Centinel Spine, Inc., (Centinel Spine), the pioneer of Stand-Alone, No-Profile®, Integrated Interbody™ fusion devices, launches MIDLINE II-Ti™, a Ti-ACTIVE™ coated, No-Profile, anterior lumbar Integrated Interbody … Continue Reading Centinel Spine® Launches MIDLINE II-Ti™ in Australia
New York, NY, May 24, 2016 – Centinel Spine, Inc., (Centinel Spine), the pioneer of Stand-Alone, No-Profile®, Integrated Interbody™ fusion devices, expands its MIDLINE II-Ti™ product family, a Ti-ACTIVE™-coated, No-Profile, … Continue Reading Centinel Spine® Expands STALIF® Internationally
NEW YORK, Jan. 21, 2016 — Centinel Spine, Inc., (Centinel Spine) announces the U.S. Food and Drug Administration (FDA) clearance of ALTOS™, a posterior cervical thoracic stabilization system indicated for use in … Continue Reading Centinel Spine® Announces the FDA Clearance and First Implantation of ALTOS™
New York, NY, July 28, 2015 – Centinel Spine, Inc., (Centinel Spine) the pioneer of Stand-Alone, No-Profile®, Integrated Interbody™ fusion devices implants its first two STALIF® MIDLINE II-Ti™ devices at … Continue Reading Centinel Spine® Implants Its First STALIF® MIDLINE II-Ti™ Device
New York, NY, June 30, 2015 – Centinel Spine, Inc., (Centinel Spine) the pioneer of Stand-Alone, No-Profile®, Integrated Interbody fusion devices was granted the first cervical multilevel indication for a Stand-Alone … Continue Reading Centinel Spine® is Granted the First Cervical Multilevel Indication for Its STALIF C® Integrated Interbody™ Device
New York, NY, June 16, 2015 – Centinel Spine®, Inc., (Centinel Spine) the pioneer of Stand-Alone, No-Profile®, Integrated Interbody™ fusion devices receive FDA clearance for its STALIF MIDLINE®, MIDLINE II™, MIDLINE II-Ti™ (Ti–ACTIVE™) … Continue Reading Centinel Spine® Receives Allogeneic Bone Graft Indication For Its Anterior Lumbar Product Family
New York, NY: June 1, 2015 – Centinel Spine, Inc. (Centinel Spine), the pioneer of spinal Stand-Alone, No-Profile®, Integrated Interbody™ devices has now implanted 20,000 STALIF C cervical Integrated Interbody … Continue Reading Centinel Spine® Passes 20,000 Implant Milestone with STALIF C® Cervical Integrated Interbody™ Devices
New York, NY, November 25, 2014 – Centinel Spine, Inc. (Centinel Spine), the pioneer of Stand-Alone, No-Profile® fusion devices, introduced MIDLINE II™, its next generation STALIF® Family Lumbar Integrated Interbody™ fusion … Continue Reading Centinel Spine® Introduces MIDLINE II™ Lumbar Integrated Interbody™ System
NEW YORK, Nov. 5, 2014 /PRNewswire/ — Centinel Spine, Inc. (Centinel Spine), the pioneer of spinal Stand-Alone, No-Profile® devices, announces the launch of Ti-ACTIVE™, a commercially-pure titanium coating, at the … Continue Reading Centinel Spine® Launches Ti-ACTIVE™ at the 2014 North American Spine Society Annual Meeting
For our full product offering, please click here, and contact a regional or district manager for further details.
Today, Centinel is pleased to announce the launch of our new website located at http://www.centinelspine.com This first phase of our new corporate website replaces the existing Centinel site and includes, … Continue Reading Centinel Spine Takes The Wraps Off Its New and Informative Website
An April 9, 2013 article in the European Spine Journal’s online edition has concluded that implants made from polyetheretherketone (PEEK) are superior to those made from titanium in maintaining intervertebral … Continue Reading Study Deems PEEK Cages Superior To Titanium